RNAi Therapeutics Market Forecast to 2027

1
RNAi Therapeutics Market Global Analysis and
Forecast to 2027

• Published Date Aug 2020

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• RNAi Therapeutics Market Forecast to 2027 -
  COVID-19 Impact and Global Analysis by Molecule
  Type (Small Interfering RNAs (siRNA) and MicroRNA
  (miRNA)) Application (Genetic Disorders,
  Oncology, Neurodegenerative Disorders,
  Cardiovascular, Respiratory Disorders, Infectious
  Diseases, Renal Diseases, and Other) Route of
  Administration (Intradermal Injections, Pulmonary
  Delivery, Intravenous Injections, Intraperitoneal
  Injections, and Others) End User (Diagnostic
  Laboratories, Research and Academic Laboratories,
  and Hospitals), and Geography

3
RNAi Therapeutics Market Overview
Email sales_at_theinsightpartners.com

• The RNAi Therapeutics market is expected to grow
  from US 618.79 million in 2019 to US 1,209.29
  million by 2027 it is expected to register a
  CAGR of 8.8 from 2020 to 2027.
• The global impacts of COVID-19 are being felt
  across several markets. In case of pharmaceutical
  industry, supply chain operations are
  significantly hampered due to the pandemic.
  However, market players in the RNAi therapeutics
  are focusing on the development of vaccine with
  the help of gene silencing technology, which
  might have a positive impact on the market growth
  during the forecast period.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• By Molecule Type (Small Interfering RNAs (siRNA)
  and MicroRNA (miRNA))
• By Application (Genetic Disorders, Oncology,
  Neurodegenerative Disorders, Cardiovascular,
  Respiratory Disorders, Infectious Diseases, Renal
  Diseases, and Other)
• By Route of Administration (Intradermal
  Injections, Pulmonary Delivery, Intravenous
  Injections, Intraperitoneal Injections, and
  Others)
• By End User (Diagnostic Laboratories, Research
  and Academic Laboratories, and Hospitals)

5
RNAi Therapeutics Market Value
Email sales_at_theinsightpartners.com

• CAGR of 8.8
• (2020 - 2027)

6
Company Profiles
Email sales_at_theinsightpartners.com

• Alnylam Pharmaceuticals, Inc.
• Sanofi
• Olix Pharmaceuticals, Inc.
• Glaxosmithkline Plc.
• Benitec Biopharma
• Arbutus Biopharma Corporation
• Silence Therapeutics
• Rexahn Pharmaceuticals, Inc.
• Arrowhead Pharmaceuticals, Inc
• Quark

7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com